Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday

Ask Mint | On Investments

Ask Mint | On Investments
Comment E-mail Print Share
First Published: Mon, Feb 18 2008. 12 38 AM IST
Updated: Mon, Feb 18 2008. 12 38 AM IST
I have some shares of Essar Steel Ltd, Enkay Taxofood Industries Ltd, Cadila Hospitals, GKN Driveline India Ltd. I am not receiving any annual report or any offer such as “buyback” for the last five years. What is status of my holding? Whom should I contact? The said companies are not answering my queries. 
Please check the registrar of the company for issues related to your details such as address, etc. You can also check the status of your shareholding by the folio number mentioned on your shares certificates. Further you may contact these companies on addresses mentioned below.
Regarding Essar Steel Ltd, you can contact the company at: Essar House, 11, Keshavrao Khadye Marg, Mahalaxmi, Mumbai. Pin: 400 034. Tel: +91-022 - 2495 0606/6660 1100, Fax: +91-022 - 2492 8896.
Regarding Enkay Texofood Industries Ltd, you may contact at: Shree Sitaram Sadan (Bhatia Bldg.) 4th Floor, 282 Shamaldas. Pin: 400 002, Tel: +91-022 2065247; Fax: +91-022 2058929. 
Cadila Hospital Product Ltd is now Cadila Healthcare Ltd. you can contact the company at: Zydus Tower, Satellite Cross Roads, Ahmadabad. Pin: 380015, Tel: +91-79-26868100;  Fax: 91-79- 26862365 
Regarding GKN Driveline India Ltd, you can contact Vibha Mittal of Mileage Communications at +91-112 -651 1423, Fax: +91-112-651 1246, mileage@vsnl.com
I have equity shares of Ambik Proteins Ltd (registered office: Vikram House, 142,Sardar Patel Colony, Naranpura, Ahmedabad). I have recently sent a request letter to the company for change of address but my request letter returned with the remark “Left”.  I have tried to search the address of the company on the Net but it is showing its old address. I request you to please let me know the present status and address of the above company.
As per the information available on the official website of the Bombay Stock Exchange, Ambik Proteins Ltd was delisted on 2 April 1996 due to non-payment of annual listing fees. Since then, there is no update on the company.
My current take-home salary is Rs34,000 and my monthly expenses are around Rs14,000. I want to invest the remaining Rs20,000 in mutual funds with 60% exposure to large-cap companies and 40% to mid- and small-cap companies. I have started monthly SIP or systematic investment plans in mutual funds such as Sundaram BNP Baribas Select Focus (Rs1,500), Sundaram BNP Baribas Select Midcap (Rs1,500), SBI Magnum Equity fund (Rs1,500), SBI Magnum Contra Fund (Rs1,500), Kotak opportunities (Rs1,500), DSP Merrill Lynch Equity (Rs2,000) since this month. For equity-linked savings scheme or ELSS, I plan to start an SIP in April in Magnum Tax Gain and Sundaram Tax Saver of Rs2,000 and Rs2,500, respectively, as I have already completed tax saving for the current year. I already have an insurance cover of Rs6 lakh for which I pay a premium of about Rs24,000 annually. I am planning to invest the remaining amount of Rs6,000 equally in HDFC Equity, DSPML TIGER and Reliance Regular Saving Funds Equity. Please advise if my goals are achievable and if any changes are required in my portfolio.
Sandeep Singh
I must appreciate you have a very diversified yet rewarding mix of schemes in your portfolio. However, you do not have much exposure to the banking sector. If you accommodate UTI Banking sector fund in your list of investments, then it might be a good value addition to your portfolio.  
I am 22 and am working in a software company earning Rs17,000 per month. Please suggest which insurance policy I should take.
Vijaya Krushna Ponnada
I think term plans are best investment options. Especially in your case, since you are very young, a term plan of any leading insurer, though preferably Life Insurance Corp. of India or ICICI Prudential, would be the best insurance option for you as the premiums in your case would be very low.
I am a medium- to long-term investor, and hold 30 shares of IDBI Bank at Rs139.25, 50 shares of Usha Martin at Rs129, five shares of Bharti Airtel at Rs942, nine shares of TCS at Rs985, 20 shares of Suzlon at Rs367 and 10 shares of ICICI Bank at Rs1,008. Up to what period should I hold these shares?
Mayuresh Bhalchandra Deo
IDBI Ltd has a one-year target of Rs196, whereas the target for Usha Martin Ltd is Rs159. Bharti Airtel Ltd is a very good long-term buy and you should hold it; you can even buy more of this stock, if it falls with the market. Same is the case with Tata Consultancy Services Ltd (TCS), which is selling very cheap at current rates. Suzlon Energy Ltd is also an excellent long-term blue-chip stock and can be held for one to four years for excellent returns. Regarding Bharti Airtel and TCS, the targets are Rs1,125 and Rs1,310, respectively. However, I would suggest you hold this stock for a period of more than two years.
I get Rs17,000 per month as salary. I want to invest Rs3 lakh lump sum now and start an SIP of Rs2,000-3,000. Please tell me which fund is a good option. Please compare Reliance Diversified Power G/Tata Infrastructure G/SBI Magnum Contra. Should I invest in just one fund? I am in settlement phase so I might need money in about 1.5-2 years if I invest today.
This is a good time to invest in a mutual funds as the NAV or net asset value of all major funds have come down in sync with the market. Regarding your query on investment, I think you should not put all your money in one fund or scheme. A mix of some funds such as DSP Merrill Lynch TIGER-Regular, Reliance Growth Fund-Growth option, Sundaram BNP Paribas Select Midcap, Tata Infrastructure, etc. ,could be a good option to invest your initial investment corpus. For SIP, you may consider UTI Banking Sector fund, SBI Magnum Contra, etc. This way you can plan a good portfolio of mutual funds, which can deliver high returns subject to market conditions.
Answers are based on a technical analysis of the markets and individual stocks. The views expressed on this page are not the newspaper’s opinion and are provided for information purposes by Vipul Verma. Readers are requested to do their own research before participating in the stock markets. Neither the paper nor the information provider will be responsible for any outcome based on information provided here.
Comment E-mail Print Share
First Published: Mon, Feb 18 2008. 12 38 AM IST